ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 618659 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 618659; 2) Community: the network communities that were significantly associated with the response to NSC 618659; 3) Molecule: the relationships between components within communities and NSC 618659; 4) MDR: the compounds that were significantly associated with the NSC 618659.

NSC Compound Enrichment Correlation
NSC 697286 LY 294002 0.00433056621075589 0.10063521
NSC 87221 Actinomycin D, 2A-D-alloisoleucine- (9CI) 0.00433056621075589 0.24409827
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.00457614317494024 0.5243288
NSC 351866 Null 0.00457614317494024 0.19346852
NSC 644945 Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6-one, 5,5a,6,8,8a,9-hexahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)- 9-[2-(dimethylamino)ethoxy]-, stereoisomer, hydrochloride 0.00457614317494024 0.45209831
NSC 647329 Null 0.00457614317494024 0.31896912
NSC 654509 Pirarubicin HCl 0.00457614317494024 0.58192409
NSC 681646 Camptothecin Derivative 0.00457614317494024 0.62590049
NSC 736157 Null 0.00457614317494024 0.1303485
NSC 678932 1H-Benzimidazole-4-carboxamide, N-[2-(dimethylamino)ethyl]-2-(4-pyridinyl)-, hydrochloride 0.00479683626511385 -0.021356728
Total:57  Current:5    [First] [Prev] [Next] [Last]